| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Busch AK, Johnson WC |
L.S.D. 25 as an aid in psychotherapy |
Dis. Nerv. System |
1950 |
| Silva F, Heath RG, Raffer... |
Comparative effects of the administration of Taraxein, d-LSD, Mescalin... |
Comprehensive Psychi... |
1960 |
| F Silva, RG Heath, T Raff... |
Comparative effects of the administration of Taraxein, d-LSD, Mescalin... |
Compreh. Psychiat. |
1960 |
| AISENBERG AC, WILES B |
Studies on the supression of immune responses by the periwinkle alkalo... |
J Clin Invest |
1964 |
| Johnson FG |
LSD in the treatment of alcoholism |
Amer. J. Psychiat. |
1969 |
| Johnson FG |
A comparison of short-term treatment effects of intravenous sodium amy... |
Canad Psychiat Ass J |
1970 |
| Johnson DW, Gunn JW |
Dangerous drugs: adulterants, diluents, and deception in street sample... |
J Forensic Sci |
1972 |
| Kang S, Johnson CL, Green... |
Theoretical Studies on the Conformations of Psilocin and Mescaline |
Molecular Pharmacolo... |
1973 |
| Johnson BD |
Understanding British-addiction statistics |
Bulletin on Narcotic... |
1975 |
| Siva Sankar DV |
LSD-a Total Study |
|
1975 |
| Gallager DW, Aghajanian G... |
Effect of Antipsychotic Drugs on the Firing of Dorsal Raphe Cells I. R... |
Europ.J.Pharmacol. |
1976 |
| Kang S, Stzelczyk M, John... |
LSD Binding To Subcellular Fractions Of Rat Brain And Inhibitory Effec... |
Fed. Proc. |
1976 |
| Siegel RK, Brewster JM, J... |
The Effects of Hallucinogens On Blind Monkeys |
Intern.Pharmacopsych... |
1976 |
| Green JP, Johnson CL, Wei... |
Antagonism of histamine-activated adenylate cyclase in brain by D-lyse... |
Proc. Natl. Acad. Sc... |
1977 |
| Weinstein H, Johnson CL, ... |
Molecular Determinants For The Action Of Tryptamines On An LSD Recepto... |
Fed. Proc. |
1977 |
| Glennon RA, Martin B, Joh... |
7,N,N-Trimethyltryptamine: a selective inhibitor of synaptosomal serot... |
Res Commun Chem Path... |
1978 |
| Green JP, Weinstein H, Ma... |
Defining the Histamine H2- Receptor in Brain: The Interaction With LSD |
QUASAR. Quantitative... |
1978 |
| Green JP, Johnson CL, Wei... |
Molecular Determinants For Interaction With The LSD Receptor: Biologic... |
Psychopharmacology o... |
1978 |
| North RA, Henderson G, Ka... |
Electrophysiological Evidence For Presynaptic Inhibition Of Acetycholi... |
Neuroscience |
1980 |
| Johnson MP, Hoffman AJ, N... |
Effects of the enantiomers of MDA, MDMA and related analogues on [3H]s... |
Eur J Pharmacol |
1986 |
| Stone DM, Johnson M, Hans... |
A comparison of the neurotoxic potential of methylenedioxyamphetamine ... |
Eur J Pharmacol |
1987 |
| Johnson M, Hanson GR, Gib... |
Effects of dopaminergic and serotonergic receptor blockade on neuroche... |
Neuropharmacology |
1988 |
| Johnson M, Letter AA, Mer... |
Effects of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamp... |
J Pharmacol Exp Ther |
1988 |
| Stone DM, Johnson M, Hans... |
Role of endogenous dopamine in the central serotonergic deficits induc... |
J Pharmacol Exp Ther |
1988 |
| Johnson M, Hanson GR, Gib... |
Effect of MK-801 on the decrease in tryptophan hydroxylase induced by ... |
Eur J Pharmacol |
1989 |
| Johnson M, Stone DM, Bush... |
Glucocorticoids and 3,4-methylenedioxymethamphetamine (MDMA)-induced n... |
Eur J Pharmacol |
1989 |
| Johnson MP, Nichols DE |
Neurotoxic effects of the alpha-ethyl homologue of MDMA following suba... |
Pharmacol Biochem Be... |
1989 |
| Nichols DE, Oberlender R,... |
Studies of dioxole ring substituted 3,4-methylenedioxyamphetamine (MDA... |
Pharmacol Biochem Be... |
1989 |
| Stone DM, Johnson M, Hans... |
Acute inactivation of tryptophan hydroxylase by amphetamine analogs in... |
Eur J Pharmacol |
1989 |
| Gibb JW, Stone DM, Johnso... |
Role of dopamine in the neurotoxicity induced by amphetamines and rela... |
NIDA Res Monogr |
1989 |
| Hanson GR, Sonsalla P, Le... |
Effects of amphetamine analogs on central nervous system neuropeptide ... |
NIDA Res Monogr |
1989 |
| Herkenham M, Lynn AB, Lit... |
Cannabinoid receptor localization in brain |
Proc Natl Acad Sci U... |
1990 |
| Gibb JW, Johnson M, Hanso... |
Neurochemical basis of neurotoxicity |
Neurotoxicology |
1990 |
| Gibb JW, Johnson M, Stone... |
MDMA: historical perspectives |
Ann N Y Acad Sci |
1990 |
| Johnson MP, Huang XM, Obe... |
Behavioral, biochemical and neurotoxicological actions of the alpha-et... |
Eur J Pharmacol |
1990 |
| Nichols DE, Brewster WK, ... |
Nonneurotoxic tetralin and indan analogues of 3,4-(methylenedioxy)amph... |
J Med Chem |
1990 |
| Johnson MP, Frescas SP, O... |
Synthesis and pharmacological examination of 1-(3-methoxy-4-methylphen... |
J Med Chem |
1991 |
| Callaway CW, Johnson MP, ... |
Amphetamine derivatives induce locomotor hyperactivity by acting as in... |
Psychopharmacology (... |
1991 |
| Huang XM, Johnson MP, Nic... |
Reduction in brain serotonin markers by alpha-ethyltryptamine (Monase) |
Eur J Pharmacol |
1991 |
| Johnson M, Bush LG, Gibb ... |
Blockade of the 3,4-methylenedioxymethamphetamine-induced changes in n... |
Eur J Pharmacol |
1991 |
| Johnson MP, Conarty PF, N... |
[3H]monoamine releasing and uptake inhibition properties of 3,4-methyl... |
Eur J Pharmacol |
1991 |
| Johnson MP, Frescas SP, O... |
Synthesis and pharmacological examination of 1-(3-methoxy-4-methylphen... |
J Med Chem |
1991 |
| Johnson MP, Huang XM, Nic... |
Serotonin neurotoxicity in rats after combined treatment with a dopami... |
Pharmacol Biochem Be... |
1991 |
| Nichols DE, Johnson MP, O... |
5-Iodo-2-aminoindan, a nonneurotoxic analogue of p-iodoamphetamine |
Pharmacol Biochem Be... |
1991 |
| Steele TD, Brewster WK, J... |
Assessment of the role of alpha-methylepinine in the neurotoxicity of ... |
Pharmacol Biochem Be... |
1991 |
| Hanson GR, Bunker CF, Joh... |
Response of monoaminergic and neuropeptide systems to 4-methylaminorex... |
Eur J Pharmacol |
1992 |
| Elayan I, Gibb JW, Hanson... |
Long-term alteration in the central monoaminergic systems of the rat b... |
Eur J Pharmacol |
1992 |
| Johnson M, Elayan I, Hans... |
Effects of 3,4-dihydroxymethamphetamine and 2,4,5-trihydroxymethamphet... |
J Pharmacol Exp Ther |
1992 |
| Johnson M, Mitros K, Ston... |
Effect of flunarizine and nimodipine on the decrease in tryptophan hyd... |
J Pharmacol Exp Ther |
1992 |
| Elayan I, Gibb JW, Hanson... |
Short-term effects of 2,4,5-trihydroxyamphetamine, 2,4,5-trihydroxymet... |
J Pharmacol Exp Ther |
1993 |
| Johnson M, Bush LG, Hanso... |
Effects of ritanserin on the 3,4-methylenedioxymethamphetamine-induced... |
Biochem Pharmacol |
1993 |
| Cohen ML, Johnson MP, Sch... |
DOI and alpha-methylserotonin: comparative vascular and nonvascular sm... |
J Pharmacol Exp Ther |
1993 |
| Johnson EJ, Emche SD |
Variation of Alkaloid Content in Erythroxylum coca Leaves from Leaf Bu... |
Annals of Botany |
1994 |
| Che S, Johnson M, Hanson ... |
Body temperature effect on methylenedioxymethamphetamine-induced acute... |
Eur J Pharmacol |
1995 |
| Sprague JE, Johnson MP, S... |
Studies on the mechanism of p-chloroamphetamine neurotoxicity |
Biochem Pharmacol |
1996 |
| Gibb JW, Johnson M, Elaya... |
Neurotoxicity of amphetamines and their metabolites |
NIDA Res Monogr |
1997 |
| Hanson GR, Jensen M, John... |
Distinct features of seizures induced by cocaine and amphetamine analo... |
Eur J Pharmacol |
1999 |
| Johnson EA, Sharp DS, Mil... |
Restraint as a stressor in mice: against the dopaminergic neurotoxicit... |
Brain Res |
2000 |
| Golub A, Johnson BD, Sifa... |
Is the U.S. experiencing an incipient epidemic of hallucinogen use? |
Subst Use Misuse |
2001 |
| Johnson EA, Shvedova AA, ... |
d-MDMA during vitamin E deficiency: effects on dopaminergic neurotoxic... |
Brain Res |
2002 |
| Johnson EA, O'Callaghan J... |
Chronic treatment with supraphysiological levels of corticosterone enh... |
Brain Res |
2002 |
| Golub A, Johnson BD |
The misuse of the ‘Gateway Theory’ in US policy on drug abuse control:... |
International Journa... |
2002 |
| Kaye J, Buchanan F, Kendr... |
Acute carbon dioxide exposure in healthy adults: evaluation of a novel... |
J Neuroendocrinol |
2004 |
| Johnson EA, O\'Callaghan ... |
Brain concentrations of d-MDMA are increased after stress |
Psychopharmacology (... |
2004 |
| Johnson BD, Bardhi F, Sif... |
Marijuana Argot as Subculture Threads |
Birt J Criminol |
2006 |
| Kirsch I, Deacon BJ, Hued... |
Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data ... |
Public Library of Sc... |
2008 |
| Uhl GR, Liu QR, Drgon T, ... |
Molecular Genetics of Successful Smoking Cessation: Convergent Genome-... |
Arch Gen Psychiatry |
2008 |
| Griffiths RR, Richards WA... |
Mystical-type experiences occasioned by psilocybin mediate the attribu... |
J Psychopharm |
2008 |
| Johnson MW, Richards WA, ... |
Human hallucinogen research: guidelines for safety |
J Psychopharmacol. |
2008 |
| Bottorff JL, Johnson JL, ... |
Relief-oriented use of marijuana by teens |
Subst Abuse Treat Pr... |
2009 |
| Johnson PM, Kenny PJ |
Dopamine D2 receptors in addiction-like reward dysfunction and compuls... |
Nat Neurosci |
2010 |
| Johnson MW, Maclean KA, R... |
Human psychopharmacology and dose-effects of salvinorin A, a kappa opi... |
Drug Alcohol Depend |
2010 |
| Johnson LA, Johnson RL, A... |
Spice: a legal marijuana equivalent |
Mil Med |
2011 |
| MacLean KA, Johnson MW, G... |
Mystical experiences occasioned by the hallucinogen psilocybin lead to... |
J Psychopharmacol |
2011 |
| Griffiths RR, Johnson MW,... |
Psilocybin occasioned mystical-type experiences: immediate and persist... |
Psychopharmacology (... |
2011 |
| Reissig CJ, Carter LP, Jo... |
High doses of dextromethorphan, an NMDA antagonist, produce effects si... |
Psychopharmacology (... |
2012 |
| Johnson LA, Johnson RL, P... |
Current 'Legal Highs' |
J Emerg Med |
2013 |
| Johnson MW, Garcia-Romeu ... |
Pilot study of the 5-HT2AR agonist psilocybin in the treatment of toba... |
J Psychopharmacol |
2014 |
| Johnson MW, MacLean KA, C... |
Time course of pharmacokinetic and hormonal effects of inhaled high-do... |
J Psychopharmacol |
2016 |
| Liao Y, Tang J, Liu J, Xi... |
Decreased Thalamocortical Connectivity in Chronic Ketamine Users |
PLoS One |
2016 |
| Paul MJ, Chisolm MS, John... |
Assessing the Validity of Online Drug Forums as a Source for Estimatin... |
J Addict Med |
2016 |
| Carbonaro TM, Bradstreet ... |
Survey study of challenging experiences after ingesting psilocybin mus... |
J Psychopharmacol |
2016 |
| Johnson MW, Garcia-Romeu ... |
An online survey of tobacco smoking cessation associated with naturali... |
J Psychopharmacol |
2017 |
| Nichols DE, Johnson MW, N... |
Psychedelics as Medicines: An Emerging New Paradigm |
Clin Pharmacol Ther |
2017 |
| Saleemi S, Pennybaker SJ,... |
Who is 'Molly'? MDMA adulterants by product name and the impact of har... |
J Psychopharmacol |
2017 |
| Barrett FS, Johnson MW, G... |
Neuroticism is associated with challenging experiences with psilocybin... |
Personality and Indi... |
2017 |
| Carbonaro TM, Johnson MW,... |
Double-blind comparison of the two hallucinogens psilocybin and dextro... |
Psychopharmacology (... |
2017 |
| Davis AK, Clifton JM, Wea... |
Survey of entity encounter experiences occasioned by inhaled N,N-dimet... |
J Psychopharmacol |
2020 |
| Nicholas B.GiancolaBAClay... |
A “trip” to the ICU: intravenous injection of psilocybin |
Journal of the Acade... |
2021 |
